Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating CC-93538 for eosinophilic esophagitis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• CC-93538

Snippet

Sponsor: Celgene | Conditions: Eosinophilic Esophagitis | Phase 3 | Status: COMPLETED | Results posted: 2025-03-13